Live
- Sri Lanka concludes sovereign bond restructuring
- Lal Krishna Advani hospitalised at Delhi's Apollo Hospital
- Modi performs puja at Triveni
- Jammu records season’s lowest minimum temperature as Kashmir valley shivers
- Scheme to give Rs 1K to women to be rolled out in 15 days
- Flirty Texts That Turn into Dates
- ‘Asli’ Sonakshi shares a glimpse of herself in ‘golden hour’
- Shraddha Kapoor took ‘thepla’ for her ‘foreign’ trip
- ChatGPT Now Supports Video Inputs: All Details
- B.Com vs BBA: Which degree better prepares you for an MBA?
Covaxin neutralises UK variant of Covid: Study
Second dose of covaxin to be distributed from today in the state
Covaxin, the Covid vaccine developed by Bharat Biotech, effectively neutralizes UK variants of SARS-CoV-2 reducing the possibility of mutant virus escape, finds a study.
Hyderabad: Covaxin, the Covid vaccine developed by Bharat Biotech, effectively neutralizes UK variants of SARS-CoV-2 reducing the possibility of mutant virus escape, finds a study.
According to a research paper carried by bioRxiv, the preprint server for biology, the study has dispelled the uncertainty of possible neutralisation escape.
A group of researchers from Indian Council of Medical Research(ICMR), National Institute of Virology, Pune and Bharat Biotech performed the plaque reduction neutralization test (PRNT50) using sera collected from the 26 recipients of BBV152/Covaxin against hCoV-19/India/20203522 (UK-variant) and hCoV27 19/India/2020Q111 (heterologous strain).
